AIM ImmunoTech Preferred Securities out of Shareholders Equity (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.34 0.00 (0.00%) USD | NYAM | Jan 16, 16:00

1.33 -0.01 (-0.75%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	--
Electromed, Inc.	--
Armata Pharmaceuticals, Inc.	--